Pfizer Says Lipitor Buyers Shouldn't Get To Redo Antitrust Suit
Pfizer Inc. and Ranbaxy Laboratories Ltd. urged a New Jersey federal court Monday to reject a bid by Lipitor purchasers to revive a pay-for-delay antitrust case over a patent settlement for...To view the full article, register now.
Already a subscriber? Click here to view full article